Monitoring Vitamin B


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
07 May 2019
Historique:
received: 05 04 2019
revised: 29 04 2019
accepted: 30 04 2019
entrez: 10 5 2019
pubmed: 10 5 2019
medline: 7 1 2020
Statut: epublish

Résumé

Metformin (MET) is currently being used in several trials for cancer prevention or treatment in non-diabetics. However, long-term MET use in diabetics is associated with lower serum levels of total vitamin B

Identifiants

pubmed: 31067706
pii: nu11051020
doi: 10.3390/nu11051020
pmc: PMC6567263
pii:
doi:

Substances chimiques

Hypoglycemic Agents 0
Transcobalamins 0
Methylmalonic Acid 8LL8S712J7
Metformin 9100L32L2N
Vitamin B 12 P6YC3EG204

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Research Council
ID : ERC-ADG-2012-322752
Pays : International

Références

Diabetes Care. 2000 Sep;23(9):1227-31
pubmed: 10977010
Am J Clin Nutr. 2003 Jul;78(1):131-6
pubmed: 12816782
J Clin Epidemiol. 2004 Apr;57(4):422-8
pubmed: 15135846
Am J Clin Nutr. 2005 Jan;81(1):110-4
pubmed: 15640468
Clin Chem Lab Med. 2005;43(10):1058-64
pubmed: 16197298
Haematologica. 2006 Feb;91(2):231-4
pubmed: 16461308
Food Nutr Bull. 2008 Jun;29(2 Suppl):S238-44
pubmed: 18709899
Am J Clin Nutr. 2009 Feb;89(2):693S-6S
pubmed: 19116323
Cell Cycle. 2009 Aug 15;8(16):2661
pubmed: 19571669
Nutr Rev. 2009 Oct;67(10):559-72
pubmed: 19785688
Br J Haematol. 2010 Jan;148(2):195-204
pubmed: 19832808
Clin Chem. 2009 Dec;55(12):2198-206
pubmed: 19833840
Indian Heart J. 2009 Mar-Apr;61(2):156-9
pubmed: 20039500
BMJ. 2010 May 20;340:c2181
pubmed: 20488910
Am J Clin Nutr. 2011 Jul;94(1):348S-358S
pubmed: 21593511
Am J Clin Nutr. 2011 Jul;94(1):313S-321S
pubmed: 21593512
Am J Clin Nutr. 2011 Aug;94(2):450-8
pubmed: 21677057
Biochimie. 2013 May;95(5):1002-7
pubmed: 23178706
N Engl J Med. 2013 Jan 10;368(2):149-60
pubmed: 23301732
J Biol Chem. 2013 May 10;288(19):13186-93
pubmed: 23539619
Trends Endocrinol Metab. 2013 Sep;24(9):469-80
pubmed: 23773243
Nutrients. 2013 Dec 10;5(12):5012-30
pubmed: 24335710
Metabolites. 2013 Nov 07;3(4):1051-75
pubmed: 24958265
Oncotarget. 2014 Jun 30;5(12):4129-43
pubmed: 24980829
Ann Transl Med. 2014 Jun;2(6):58
pubmed: 25333033
Biochem J. 2015 Jul 15;469(2):177-87
pubmed: 25940306
J Clin Endocrinol Metab. 2016 Apr;101(4):1754-61
pubmed: 26900641
Diabetes Metab. 2016 Nov;42(5):316-327
pubmed: 27130885
Mol Metab. 2016 Aug 26;5(10):1048-1056
pubmed: 27689018
Tumori. 2018 Mar-Apr;104(2):137-142
pubmed: 28106245
Cell Discov. 2017 Jul 04;3:17022
pubmed: 28698800
Ageing Res Rev. 2017 Nov;40:31-44
pubmed: 28802803
Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):627-635
pubmed: 29618465
Diabetes Obes Metab. 2018 Aug;20(8):1951-1956
pubmed: 29667290
J Diabetes. 2019 Jan 7;:null
pubmed: 30615306

Auteurs

Antonio Mastroianni (A)

Laboratory Medicine-Department of Pathology and Laboratory Medicine, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. antonio.mastroianni@istitutotumori.mi.it.

Chiara Maura Ciniselli (CM)

Bioinformatics and Biostatistics Unit-Department of Applied Research and Technological Development, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. chiara.ciniselli@istitutotumori.mi.it.

Rossella Panella (R)

Laboratory Medicine-Department of Pathology and Laboratory Medicine, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. rossella.panella@istitutotumori.mi.it.

Alessandra Macciotta (A)

Bioinformatics and Biostatistics Unit-Department of Applied Research and Technological Development, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. alessandra.macciotta@istitutotumori.mi.it.

Adalberto Cavalleri (A)

Epidemiology and Prevention Unit-Department of Research, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. adalberto.cavaller@istitutotumori.mi.it.

Elisabetta Venturelli (E)

Epidemiology and Prevention Unit-Department of Research, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. elisabetta.venturelli@istitutotumori.mi.it.

Francesca Taverna (F)

Immunohematology and Transfusion Medicine Service-Department of Research, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. francesca.taverna@istitutotumori.mi.it.

Arabella Mazzocchi (A)

Epidemiology and Prevention Unit-Department of Research, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. arabella.mazzocchi@istitutotumori.mi.it.

Eleonora Bruno (E)

Epidemiology and Prevention Unit-Department of Research, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. eleonora.bruno@istitutotumori.mi.it.

Paola Muti (P)

Chair Cancer Experimental Therapeutics, Department of Oncology Faculty of Health Science, McMaster University, Hamilton, ON L8V 1C3, Canada. muti@mcmaster.ca.

Franco Berrino (F)

Epidemiology and Prevention Unit-Department of Research, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. franco.berrino@istitutotumori.mi.it.

Paolo Verderio (P)

Bioinformatics and Biostatistics Unit-Department of Applied Research and Technological Development, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. paolo.verderio@istitutotumori.mi.it.

Daniele Morelli (D)

Laboratory Medicine-Department of Pathology and Laboratory Medicine, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. daniele.morelli@istitutotumori.mi.it.

Patrizia Pasanisi (P)

Epidemiology and Prevention Unit-Department of Research, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy. patrizia.pasanisi@istitutotumori.mi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH